A groundbreaking new study finds synthetic (GMO) insulin is capable of rapidly producing type 1 diabetes in type 2 diabetics.
Last year, we reported on the dangers of insulin therapy for type 2 diabetics, following the publication of a study comprised of almost 85,000 type 2 diabetic patients that found insulin monotherapy doubled their risk of all-cause mortality, in addition to significantly increasing their risk for diabetes-related complications and cancer. Insulin monotherapy resulted in:
Now, a new study published in the Journal of Clinical Endocrinology & Metabolism titled, “Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype,” is shedding light on a possible explanation for why insulin treatment may accelerate morbidity and mortality in type 2 diabetics. The study revealed that giving genetically susceptible type 2 diabetes patients recombinant insulin can trigger their bodies to target their own insulin producing cells for autoimmune destruction, effectively producing ‘double diabetes’: type 1 and type 2, as a result.
The Japanese study took 6 patients (4 men and 2 women) with type 2 diabetes, none of whom had previously received insulin therapy nor had markers for autoantibodies to their own insulin (e.g. GAD65). All patients were found to have the type 1 diabetes susceptibility gene known as type 1 diabetes high risk HLA class II (IDDM1), which is considered to play a role in up to 50% of type 1 diabetes cases, and the insulin gene VNTR genotype (IDDM2), believed to play a key role in susceptibility to type 2 diabetes.
After recombinant insulin administration their blood glucose control deteriorated, and their own insulin producing beta cells – as measured by declining C-peptide levels (a marker for the production of natural insulin) – decreased insulin production to a deficiency levels commonly found in type 1 diabetes patients. The average time it took for the patients to develop full blown type 1 diabetes was 7.7 months, with one patient developing the condition within 1.1 months.
Further tests revealed that the patients had antibodies against their own pancreatic islet cells (the cells responsible for producing insulin), insulin allergy or increased levels of insulin antibody. Additionally, 2 of 4 cases were found to have GAD-reactive and insulin peptide reactive Th1 cells, typical markers of autoimmunity induced type 1 diabetes.
The researchers concluded from their findings:
“The findings suggest that insulin administration may have triggered TIDM in patients with T2DM. IDDM1 and IDDM 2 as well as autoreactive T cells may contribute to the development of T1DM. Developing insulin-triggered T1DM if a patient’s blood glucose control acutely deteriorates after insulin administration should be carefully considered.”
The researchers also pointed out that there are a number trials underway to produce vaccines containing insulin intended to induce a ‘tolerogenic immune response’ and therefore ameliorate autoimmune type 1 diabetes. Clearly, however, their findings run contrary to this expectation, revealing that it is possible that introducing exogenous forms of insulin may stimulate the opposite reaction and induced autoimmunity against the hormone, or the cells in the pancreas responsible for producing it.
A possible explanation for these results lies in the difference between today’s synthetic insulin and insulin purified from animals such as pigs (porcine insulin), which is no longer available in countries like the U.S. Read the rest Here.
Billions are spent annually and still there is no conventional cure for diabetes. Or is there a cheap, safe and freely available solution already growing beneath our feet?
Diabetes is a very big business, representing tens of billion of dollars in pharmaceutical drug sales annually. Tragically, while the number of diabetes diagnoses continue to expand globally the drugs themselves, including recombinant (GMO produced) insulin, appear to actually increase mortality. Upton Sinclair nailed the problem on its head when he stated:
It is difficult to get a man to understand something, when his salary depends on his not understanding it.”
In other words, the resistance within the conventional medical system against finding both the causes and the cures for the diabetes epidemic is institutional, economically-motivated, and fundamentally unethical.
This happens to be why GreenMedInfo.com continues to enjoy expanding popularity around the world. There is no shortage of research on natural solutions to both type 1 and type 2 diabetes, but with the mainstream media’s primary funding coming from Big Pharma, the storylines either completely ignore or are pitted against the natural solutions we regularly report on. Back in 2014, for instance, we reported on a truly groundbreaking finding published in the American Diabetes Association’s very own journal, Diabetes Care, which found a turmeric extract (curcumin) was100% effective in preventing the progression from pre-diabetes to diabetes (type 2).
Obviously, turmeric possesses a wide range of side benefits, making this finding all the more promising for those under conventional care. Clearly, if these spectacular results had been obtained through an FDA approved drug instead of a plant that grows freely, it would have made global headlines as one of the greatest achievements of modern pharmaceutical medicine history.
Sayer Ji is founder of Greenmedinfo.com, on the Board of Governors for the National Health Federation, and Fearless Parent, Steering Committee Member of the Global GMO Free Coalition (GGFC), a reviewer at the International Journal of Human Nutrition and Functional Medicine.
Providence Capital Financing is among the leading service providers of commercial financing in the country. Established in 2020, the company has grown to be one of the most revered names in industrial finance. Companies rely on the business enterprise plans provided by Charité Capital Reduced stress because each uses the same impressive approach to discover...
Information systems is a broad topic that encompasses application, components, systems and information. That is an overview info systems point of view and helps the company owners to discover the important thing areas within their organization that require improvement. First of all to understand about facts systems is that it doesn’t merely happen. It is...
today we are going to talk about how to establish the importance of your research study you will most often see this section called the background or literature review this step is of critical importance to any research proposal ethics proposal dissertation or publications be sure to check the guidelines wherever you are submitting your...